Quantitative Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $645K | Buy |
8,063
+3,898
| +94% | +$321K | 0.07% | 258 |
|
|
2025
Q4 | $355K | Buy |
+4,165
| New | +$342K | 0.03% | 345 |
|
|
2025
Q3 | – | Sell |
-17,362
| Closed | -$1.36M | – | 387 |
|
|
2025
Q2 | $1.36M | Buy |
+17,362
| New | +$1.29M | 0.18% | 111 |
|
|
2024
Q4 | – | Sell |
-140,101
| Closed | -$9.24M | – | 369 |
|
|
2024
Q3 | $9.24M | Buy |
+140,101
| New | +$10.2M | 0.91% | 26 |
|
|
2023
Q4 | – | Sell |
-39,297
| Closed | -$2.72M | – | 326 |
|
|
2023
Q3 | $2.72M | Sell |
39,297
-10,245
| -21% | -$823K | 0.42% | 56 |
|
|
2023
Q2 | $4.67M | Buy |
49,542
+29,482
| +147% | +$2.56M | 0.44% | 51 |
|
|
2023
Q1 | $1.66M | Buy |
20,060
+5,488
| +38% | +$431K | 0.35% | 78 |
|
|
2022
Q4 | $1.09M | Buy |
14,572
+5,270
| +57% | +$406K | 0.21% | 91 |
|
|
2022
Q3 | $768K | Buy |
+9,302
| New | +$895K | 0.13% | 160 |
|
|
2022
Q1 | – | Sell |
-10,308
| Closed | -$1.33M | – | 243 |
|
|
2021
Q4 | $1.33M | Buy |
+10,308
| New | +$1.2M | 0.19% | 106 |
|
|
2021
Q3 | – | Sell |
-2,247
| Closed | -$232K | – | 431 |
|
|
2021
Q2 | $232K | Sell |
2,247
-1,557
| -41% | -$147K | 0.02% | 352 |
|
|
2021
Q1 | $318K | Buy |
+3,804
| New | +$322K | 0.03% | 398 |
|
|
2020
Q1 | – | Sell |
-32,946
| Closed | -$2.56M | – | 600 |
|
|
2019
Q4 | $2.56M | Buy |
+32,946
| New | +$2.57M | 0.08% | 262 |
|
|
2019
Q3 | – | Sell |
-194,367
| Closed | -$12M | – | 643 |
|
|
2019
Q2 | $12M | Buy |
194,367
+155,667
| +402% | +$9.41M | 0.46% | 45 |
|
|
2019
Q1 | $2.47M | Buy |
+38,700
| New | +$2.21M | 0.14% | 193 |
|
|
2018
Q4 | – | Sell |
-80,400
| Closed | -$4.67M | – | 644 |
|
|
2018
Q3 | $4.67M | Sell |
80,400
-124,800
| -61% | -$6.1M | 0.16% | 102 |
|
|
2018
Q2 | $9.96M | Buy |
205,200
+48,900
| +31% | +$2.28M | 0.21% | 105 |
|
|
2018
Q1 | $7.27M | Buy |
156,300
+43,800
| +39% | +$1.9M | 0.13% | 197 |
|
|
2017
Q4 | $4.23M | Sell |
112,500
-771,600
| -87% | -$28.3M | 0.06% | 348 |
|
|
2017
Q3 | $32.2M | Buy |
+884,100
| New | +$33.7M | 0.37% | 58 |
|
|
2016
Q3 | – | Sell |
-230,100
| Closed | -$7.65M | – | 719 |
|
|
2016
Q2 | $7.65M | Buy |
230,100
+169,500
| +280% | +$5.8M | 0.36% | 64 |
|
|
2016
Q1 | $1.78M | Buy |
60,600
+51,000
| +531% | +$1.41M | 0.09% | 282 |
|
|
2015
Q4 | $252K | Sell |
9,600
-10,800
| -53% | -$280K | 0.02% | 610 |
|
|
2015
Q3 | $483K | Sell |
20,400
-58,200
| -74% | -$1.4M | 0.04% | 450 |
|
|
2015
Q2 | $1.86M | Buy |
+78,600
| New | +$1.77M | 0.28% | 78 |
|
|
2014
Q2 | – | Sell |
-168,600
| Closed | -$2.08M | – | 514 |
|
|
2014
Q1 | $2.08M | Buy |
+168,600
| New | +$1.95M | 0.1% | 144 |
|
|
2013
Q3 | – | Sell |
-43,200
| Closed | -$483K | – | 564 |
|
|
2013
Q2 | $483K | Buy |
+43,200
| New | +$511K | 0.09% | 247 |
|
Other funds holding EW
VCM
VPM
Quantitative Investment Management's EW Position: Q1 2026 in Review
Quantitative Investment Management increased its Edwards Lifesciences (EW) stake by 94% in Q1 2026, buying an estimated $321K and bringing the position to 8,063 shares worth $645K. The position accounts for 0.07% of the portfolio, ranked #258.
Quantitative Investment Management first reported a position in EW in Q2 2013 and has held it in 27 quarters since. The position peaked at $32.2M in Q3 2017. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Quantitative Investment Management held 8,063 shares of Edwards Lifesciences worth $645K as of Q1 2026.
- Quantitative Investment Management bought 3,898 Edwards Lifesciences shares in Q1 2026, an estimated $321K.
- Edwards Lifesciences made up 0.07% of Quantitative Investment Management's portfolio in Q1 2026, its #258 holding.
- Quantitative Investment Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 27 quarters since.
- Quantitative Investment Management's Edwards Lifesciences position peaked at $32.2M in Q3 2017.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.